Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Karyopharm Therapeut (KPTI)

14.84   0.14 (0.95%) 09-27 21:37
Open: 14.74 Pre. Close: 14.7
High: 15.17 Low: 14.4038
Volume: 2,115,291 Market Cap: 1,090M
Karyopharm Therapeutics, Inc. is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. The company is headquartered in Newton Center, Massachusetts and currently employs 332 full-time employees. The firm is focused on the discovery, development, and commercialization of drugs directed against nuclear export and related targets for the treatment of cancer and other diseases. Its selective inhibitor of nuclear export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Its lead compound, XPOVIOTM (selinexor), received accelerated approval from the Food and Drug Administration (FDA), in combination with dexamethasone as a treatment for patients with heavily pretreated multiple myeloma. Its XPOVIO is an oral SINE compound, which blocks the nuclear export of tumor suppressor, growth regulatory and anti-inflammatory proteins, leading to accumulation of these proteins in the nucleus and enhancing their anti-cancer activity in the cell. The company is also focused on developing treatments for other diseases, such as Hematologic Malignancies and Solid Tumor Malignancies.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 15.192 - 15.277 15.277 - 15.355
Low: 14.181 - 14.289 14.289 - 14.389
Close: 14.68 - 14.84 14.84 - 14.986

Technical analysis

as of: 2020-09-25 4:31:59 PM
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 18.05     One year: 19.25
Support: Support1: 13.80    Support2: 11.48
Resistance: Resistance1: 15.46    Resistance2: 16.48
Pivot: 15.37
Moving Average: MA(5): 15.35     MA(20): 15.34
MA(100): 17.24     MA(250): 17.23
MACD: MACD(12,26): -0.07     Signal(9): -0.07
Stochastic oscillator: %K(14,3): 31.13     %D(3): 50.41
RSI: RSI(14): 44.23
52-week: High: 29.61  Low: 8.91  Change(%): 54.3
Average Vol(K): 3-Month: 146372  10-Days: 146265

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
KPTI has closed above bottom band by 30.0%. Bollinger Bands are 23.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 09 Jun 2020
Karyopharm Announces Dosing of First Patient in a Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Patients with Newly Diagnosed or Recurrent Glioblastoma - GlobeNewswire

Mon, 01 Jun 2020
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Tue, 26 May 2020
Karyopharm Announces Investor Conference Call to Discuss Phase 3 BOSTON Data To Be Presented at the American Society of Clinical Oncology 2020 Virtual Scientific Program - GlobeNewswire

Tue, 26 May 2020
Karyopharm to Participate at Jefferies Virtual Healthcare Conference - GlobeNewswire

Wed, 20 May 2020
Karyopharm Submits Supplemental New Drug Application to FDA for XPOVIO® (selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Line of Therapy - GlobeNewswire

Tue, 12 May 2020
Karyopharm to Participate at 2020 RBC Capital Markets Global Healthcare Virtual Conference - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 73
Shares Float (M) 49
% Held by Insiders 12.78
% Held by Institutions 91.03
Shares Short (K) 14,280
Shares Short P. Month (K) 15,570

Stock Financials

EPS -2.840
EPS Est This Year -2.620
EPS Est Next Year -2.310
Book Value (p.s.) 1.770
Profit Margin -228.44
Operating Margin -205.49
Return on Assets (ttm) -34.5
Return on Equity (ttm) -178.4
Qtrly Rev. Growth 253.0
Gross Profit (p.s.) -1.141
Sales Per Share 1.128
EBITDA (p.s.) -2.305
Qtrly Earnings Growth
Operating Cash Flow (M) -161
Levered Free Cash Flow (M) -91

Stock Valuations

PE Ratio -5.23
PEG Ratio
Price to Book value 8.38
Price to Sales 13.15
Price to Cash Flow -6.76

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.